According to Zymeworks's latest financial reports the company has a price-to-book ratio of 1.33.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.56 | 55.78% |
2022-12-31 | 1.00 | -74.27% |
2021-12-31 | 3.90 | -26.3% |
2020-12-31 | 5.30 | -27.64% |
2019-12-31 | 7.32 | 181.48% |
2018-12-31 | 2.60 | 57.15% |
2017-12-31 | 1.66 | |
2016-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.81 | 111.07% | ๐บ๐ธ USA |